Reducing Treatment Burden in IBD with At-Home Therapy Options - Episode 1
Reducing Treatment Burden in IBD with At-Home Therapy Options
Published on:
Jean-Frederic Colombel, MD, offers insights into subcutaneous infliximab-dyyb injection, detailing its administration and approved indications for ulcerative colitis and Crohn's disease.
- The FDA has now approved a subcutaneous infliximab injection for IBD. Can you provide an overview of subcutaneous infliximab-dyyb injection? What is the significance of this approval?
- How could this impact patients with UC and CD?
- What are the indications for subcutaneous infliximab-dyyb injection?
- When and how can this therapy be started?
